Protocol No.: VGN-TED-301

Title
A Phase 2b, Randomized, Double-Mask, Placebo Controlled, Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Linsitinib in Subjects with Active, Moderate to Severe Thyroid Eye Disease
Principal Investigator
Nguyen, John
Phase
II
Age Group
Adult
Applicable Disease Site
Ophthalmology
Participating Institutions
Eye Institute
West Virginia University
Contacts
Cassidy Pinion
Research Assistant
Phone: +1 304-598-6956
Christina Sundar, CRC
Clinical Research Coordinator
Phone: +1 304-598-6956
Maria Auber
Clinical Research Coordinator
Phone: +1 304-598-6135

View on ClinicalTrials.gov